---
schema_version: "secwatch.filing_event.v1"
accession: "0000055529-26-000017"
form_type: "8-K"
ticker: "KEQU"
cik: "0000055529"
company_name: "KEWAUNEE SCIENTIFIC CORP /DE/"
filed_at: "2026-06-23T21:10:03+00:00"
generated_at: "2026-06-23T21:12:44.786367+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "medium"
source: SEC EDGAR
---

# Kewaunee Scientific reports FY2026 revenue up 17.3% to $282M; EPS down to $3.22 from $3.83

## Summary
- Full-year sales $281.999M (+17.3% YoY); net earnings $9.618M vs $11.405M prior year.
- Diluted EPS $3.22 compared to $3.83; EBITDA $22.425M vs $21.613M.
- Lab Products Group segment sales $214.886M (+19.8%), net earnings $14.156M vs $15.370M.
- Company cites challenging market conditions including tariff costs, partly offset by productivity gains.
- Nu Aire integration and balance sheet improvement noted as positives.

## SEC filing metadata
- accession: 0000055529-26-000017
- form_type: 8-K
- ticker: KEQU
- cik: 0000055529
- company_name: KEWAUNEE SCIENTIFIC CORP /DE/
- filed_at: 2026-06-23T21:10:03+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: medium
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/55529/000005552926000017/0000055529-26-000017-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/55529/000005552926000017/kequ-20260623.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000055529-26-000017
- JSON: https://secwatch.observer/filing/0000055529-26-000017.json
- Plain text: https://secwatch.observer/filing/0000055529-26-000017.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.